Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Ono-4057 useful in organ transplants according to results presented at Japanese congress

Dec. 29, 1998

Hyseq presents gene product with potential application to vaccine development

Dec. 28, 1998

Disposition of L-732351, a semisynthetic macrolide immunosuppressant, in animals

Dec. 23, 1998

FDA approves first Lyme disease vaccine

Dec. 22, 1998

Abgenix completes phase II clinical trial in GVHD

Dec. 22, 1998

Abgenix and RCT enter CD45RB antibody collaboration

Dec. 21, 1998

Novartis updates status of immunosuppressive agent

Dec. 17, 1998

SmithKline Beecham and Ribi announce positive HBV phase III trial data

Dec. 16, 1998

MedImmune and BioTransplant initiate two new clinical studies of MEDI-507

Dec. 16, 1998

Vanguard Medica takes on development of imiquimod analogue

Dec. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...